Free Trial

What is Stifel Canada's Forecast for kneat.com Q1 Earnings?

kneat.com logo with Medical background

Key Points

  • Stifel Canada forecasts kneat.com will post earnings of ($0.04) per share for Q1 2026, consistent with quarterly estimates for Q2, Q3, and Q4.
  • Raymond James Financial has lowered their price target for kneat.com from C$7.50 to C$7.00 while maintaining an "outperform" rating.
  • Kneat.com stock has recently traded at C$5.90, down C$0.12, with a market capitalization of C$551.66 million.
  • Want stock alerts on kneat.com? Get 5 Weeks of MarketBeat All Access for $5. Get My Stock Alerts.

kneat.com, inc. (TSE:KSI - Free Report) - Equities research analysts at Stifel Canada issued their Q1 2026 earnings estimates for shares of kneat.com in a report released on Wednesday, August 6th. Stifel Canada analyst J. Keywood anticipates that the company will post earnings per share of ($0.04) for the quarter. The consensus estimate for kneat.com's current full-year earnings is ($0.12) per share. Stifel Canada also issued estimates for kneat.com's Q2 2026 earnings at ($0.04) EPS, Q3 2026 earnings at ($0.04) EPS and Q4 2026 earnings at ($0.04) EPS.

Separately, Raymond James Financial reduced their price target on shares of kneat.com from C$7.50 to C$7.00 and set an "outperform" rating on the stock in a research note on Wednesday.

View Our Latest Stock Analysis on kneat.com

kneat.com Price Performance

Shares of KSI traded down C$0.12 during mid-day trading on Friday, reaching C$5.90. The company had a trading volume of 574,272 shares, compared to its average volume of 93,188. The company's 50 day simple moving average is C$6.03 and its 200 day simple moving average is C$6.26. kneat.com has a 1-year low of C$4.40 and a 1-year high of C$7.25. The company has a debt-to-equity ratio of 85.50, a quick ratio of 1.50 and a current ratio of 1.43. The company has a market capitalization of C$551.66 million, a price-to-earnings ratio of -63.73, a P/E/G ratio of 597.67 and a beta of 1.08.

About kneat.com

(Get Free Report)

kneat.com Inc is in the business of developing and marketing a software application for modelling regulated data-intensive processes for regulated industries, focusing on the life sciences industry. The company has developed Kneat Gx solution which provides management real-time visibility and control and increases product, quality, and compliance.

Recommended Stories

Earnings History and Estimates for kneat.com (TSE:KSI)

Should You Invest $1,000 in kneat.com Right Now?

Before you consider kneat.com, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and kneat.com wasn't on the list.

While kneat.com currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Buy-the-Dip Stocks Poised to Rebound Soon
Quantum Boom: 3 Strong Picks with Lower Risk
3 Overlooked AI Stocks That Chipmakers Can’t Live Without

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines